Dr. Zehra Naz
Category: September 10, 2015
Personal Information
Campus Karachi  

Dr Zehra Naz

 

 

Department Biochemistry
Designation Professor
Name Dr. Zehra Naz
E mail drzehranaz@gmail.com
Phone (Office Ext) 99204685-1053
Research Area Biochemistry (Prostate diseases, Sweeteners, )
Number of Publications Eight

 

Qualification
Degree Passing Year Majors University
MBBS 1998 Bachelors of Surgery and Medicine Sindh Medical College/ Karachi University
MPhil

 

2004 Biochemistry Basic Medical Sciences Institute, JPMC/ Karachi University
FCPS 2011 Biochemistry Army Medical College/ College of Physicians and Surgeons, Pakistan
PGD Professional Ethics and Teaching Methodology 2013 Ethics And Teaching Methodology Riphah International University, Islamabad

 

Teaching Experience
Designation From To Organization
Lecturer / Demonstrator 2000 2001 Sir Syed College of Medical Sciences, Karachi
MPhil Trainee 2001 2004 Basic Medical Sciences Institute, JPMC, Karachi
Assistant Professor 2004 2005 Jinnah Medical and Dental College, Karachi
Head of Department/ Assistant Professor 2006 2008 Fatima Jinnah Dental College, Karachi
FCPS II Trainee 2009 2011 Army Medical College, Rawalpindi
Acting Head of Department/ Assistant Professor 2011

 

2012

 

Islamic International Medical College, Rawalpindi
Head of Department/ Associate Professor 2012 2013 Islamic International Medical College, Rawalpindi
MPhil Supervisor 2011 2013 Islamic International Medical College, Rawalpindi
Associate Professor 2013 2016 Bahria University Medical and Dental College, Karachi
Professor 2016 Till to date Bahria University Medical and Dental College, Karachi

 

Publications
1.    Prostate Specific Antigen in Benign prostatic hyperplasia and Carcinoma Prostate (M. Phil research project and thesis).
2.    Is Diet A Risk Factor For Benign Prostatic Hyperplasia And Carcinoma Prostate? Pak J Med Sci 2010; 26(4):959-963. (1st author) (W category)
3.    Assessment of Cerebral Perfusion in Chronic Tobacco Users through SPECT Using Tc-99m HMPAO. Pak Armed Forces Med J 2010; 60(3): 348-55. (5th author) (Y category)
4.    Effect of Anthropometric Measurements and Personal Data Parameters on Benign Prostatic Hyperplasia and Carcinoma Prostate. J Ayub Med Coll 2010; 22(3):54-7. (1st author) (Y category)
5.    Effect of Post-Myocardial Infarction Streptokinase Therapy on Myocardial Viability-Evaluation with Th-201 SPECT. Pak Armed Forces Med J 2011; 61(3): 348-55 (3rd author) (Y category)
6.    Prostate Specific Antigen, Alkaline Phosphatase, Urea, Creatinine and Haemoglobin in Benign Prostatic Hyperplasia and Carcinoma Prostate. Med Chan 2012; 19 (2): 5-8 (1st author) (Y category)
7.    SERUM PROSTATE SPECIFIC ANTIGEN (PSA). Professional Medical Journal 2013; 20(1): 017-022 (1st author) (X category)
8.    Effect of fructose and galactose on blood lipids, glucose, and HbA1c in rats (FCPS II research project and thesis).
9.    ‘Is Fructose an Ideal Sweetening Agent?’ abstract published in the abstract book of the 5th International Conference on Drug Discovery and Therapy, Dubai, 2013.
10. Fructose; Is It an Ideal Sweetening Agent? Professional Medical Journal 2014; 21(1): 136-143 (1st author) (X category)
11. Exercise tolerance test (ETT) or myocardial perfusion scan (MPS)-What to choose in patients of ischaemic heart disease (IHD). Pak Armed Forces Med J 2014; 64(2): 212-218 (3rd author) (Y category)

 

pedasbet slot online slot online 2024 slot gacor slot gacor 2024 slot paling gacor 2024 slot dana Pedasbet Pedasbet Pedasbet Pedasbet
koin25hoki slot69 barito88 vita4d vita4d vita4d vita4d